Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
2004 1
2005 3
2006 2
2007 4
2008 1
2009 3
2011 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Molecular on/off switch.
Milton DT, Riely GJ, Pao W, Miller VA, Kris MG, Heelan RT. Milton DT, et al. J Clin Oncol. 2006 Oct 20;24(30):4940-2. doi: 10.1200/JCO.2006.06.4410. J Clin Oncol. 2006. PMID: 17050880 No abstract available.
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus.
Riely GJ, Kris MG, Zhao B, Akhurst T, Milton DT, Moore E, Tyson L, Pao W, Rizvi NA, Schwartz LH, Miller VA. Riely GJ, et al. Among authors: milton dt. Clin Cancer Res. 2007 Sep 1;13(17):5150-5. doi: 10.1158/1078-0432.CCR-07-0560. Clin Cancer Res. 2007. PMID: 17785570 Free article.
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.
Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G. Keedy VL, et al. Among authors: milton dt. J Clin Oncol. 2011 May 20;29(15):2121-7. doi: 10.1200/JCO.2010.31.8923. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482992
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page